Mathew C. Finniss

Incorporation and Controlled Release of Silyl Ether Prodrugs from PRINT Nanoparticles

Matthew C. Parrott, Mathew C. Finniss, J. Chris Luft et al. · Journal of the American Chemical Society · 2012 · 127 citations

Pharmacy, Medicinal Chemistry, Pharmaceutics +17

Nanoparticle drug loading as a design parameter to improve docetaxel pharmacokinetics and efficacy

Kevin S. Chu, Allison N. Schorzman, Mathew C. Finniss et al. · Biomaterials · 2013 · 123 citations · Full text

Pharmacy, Pharmaceutics, Pharmacokinetics +16

Particle Replication in Nonwetting Templates Nanoparticles with Tumor Selective Alkyl Silyl Ether Docetaxel Prodrug Reduces Toxicity

Kevin S. Chu, Mathew C. Finniss, Allison N. Schorzman et al. · Nano Letters · 2014 · 46 citations

Pharmacy, Pharmaceutics, Pharmacology +17

A versatile acid-labile linker for antibody–drug conjugates

Mathew C. Finniss, Kevin S. Chu, Charles J. Bowerman et al. · MedChemComm · 2014 · 17 citations

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +13

A case of gastrointestinal histoplasmosis with esophageal involvement

Mathew C. Finniss, Paul Lewis, James W. Myers et al. · Clinical Journal of Gastroenterology · 2019 · 10 citations

Medicine, Infectious Diseases, Pathology +14